{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["12(3)"],"submitter":["Livingston JM"],"pubmed_abstract":["Stroke is the leading cause of adult disability worldwide. The majority of stroke survivors are left with devastating functional impairments for which few treatment options exist. Recently, a number of studies have used ectopic expression of transcription factors that direct neuronal cell fate with the intention of converting astrocytes to neurons in various models of brain injury and disease. While there have been reports that question whether astrocyte-to-neuron conversion occurs in vivo, here, we have asked if ectopic expression of the transcription factor <i>Neurod1</i> is sufficient to promote improved functional outcomes when delivered in the subacute phase following endothelin-1-induced sensory-motor cortex stroke. We used an adeno-associated virus to deliver <i>Neurod1</i> from the short GFAP promoter and demonstrated improved functional outcomes as early as 28 days post-stroke and persisting to at least 63 days post-stroke. Using <i>Cre</i>-based cell fate tracking, we showed that functional recovery correlated with the expression of neuronal markers in transduced cells by 28 days post-stroke. By 63 days post-stroke, the reporter-expressing cells comprised ~20% of all the neurons in the perilesional cortex and expressed markers of cortical neuron subtypes. Overall, our findings indicate that ectopic expression of <i>Neurod1</i> in the stroke-injured brain is sufficient to enhance neural repair."],"journal":["Biomedicines"],"pagination":["663"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC10968474"],"repository":["biostudies-literature"],"pubmed_title":["Ectopic Expression of Neurod1 Is Sufficient for Functional Recovery following a Sensory-Motor Cortical Stroke."],"pmcid":["PMC10968474"],"pubmed_authors":["Livingston JM","Phillips CM","Donville BW","Lozano Casasbuenas D","Ibragimov OS","Enbar T","Krassikova A","Kortebi I","Morshead CM","Daniele E","Sachewsky N","Bang KWA","Lee TT","Olfat A"],"additional_accession":[]},"is_claimable":false,"name":"Ectopic Expression of Neurod1 Is Sufficient for Functional Recovery following a Sensory-Motor Cortical Stroke.","description":"Stroke is the leading cause of adult disability worldwide. The majority of stroke survivors are left with devastating functional impairments for which few treatment options exist. Recently, a number of studies have used ectopic expression of transcription factors that direct neuronal cell fate with the intention of converting astrocytes to neurons in various models of brain injury and disease. While there have been reports that question whether astrocyte-to-neuron conversion occurs in vivo, here, we have asked if ectopic expression of the transcription factor <i>Neurod1</i> is sufficient to promote improved functional outcomes when delivered in the subacute phase following endothelin-1-induced sensory-motor cortex stroke. We used an adeno-associated virus to deliver <i>Neurod1</i> from the short GFAP promoter and demonstrated improved functional outcomes as early as 28 days post-stroke and persisting to at least 63 days post-stroke. Using <i>Cre</i>-based cell fate tracking, we showed that functional recovery correlated with the expression of neuronal markers in transduced cells by 28 days post-stroke. By 63 days post-stroke, the reporter-expressing cells comprised ~20% of all the neurons in the perilesional cortex and expressed markers of cortical neuron subtypes. Overall, our findings indicate that ectopic expression of <i>Neurod1</i> in the stroke-injured brain is sufficient to enhance neural repair.","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Mar","modification":"2025-04-04T23:53:56.83Z","creation":"2025-04-04T23:53:56.83Z"},"accession":"S-EPMC10968474","cross_references":{"pubmed":["38540276"],"doi":["10.3390/biomedicines12030663"]}}